Rob Coleman, MD
Chief Medical Officer, Sarah Cannon Research Institute
Dr. Coleman serves as the chief medical officer for Sarah Cannon Research Institute (SCRI). In March 2020, Dr. Coleman joined US Oncology Research, and served as the chief scientific officer prior to the joint venture that was formed with SCRI later that year. In his role with SCRI, Dr. Coleman oversees clinical operations across SCRI’s newly-combined research network.
Dr. Coleman completed his obstetrics & gynecology residency at Northwestern University Medical Center in Chicago, and completed his fellowship at The University of Texas MD Anderson Cancer Center in 1993. Prior to joining the MD Anderson faculty in 2004, he served as vice chairman for the Department of Obstetrics and Gynecology at the University of Texas, Southwestern Medical Center in Dallas. At MD Anderson, Dr. Coleman was professor and served as the executive director for Cancer Network Research, holding the Ann Rife Cox Chair in Gynecology.
Dr. Coleman has authored or co-authored more than 650 scientific publications, including more than 370 peer-reviewed articles, along with numerous book chapters, monographs, invited articles and textbooks. In 2019, he received the 2019 APGO-CREOG Award for Excellence in Teaching and the 2023 Society of Gynecologic Oncology (SGO) Innovator Award. He is a co-director for GOG-Partners and serves on the Board of Directors for GOG-Foundation, Inc. He served as president of the SGO (2015-2016) and is the immediate past-president of the International Gynecologic Cancer Society (IGCS, 2020-2022). He was inducted into MJH Life Sciences™ “Giants in Cancer Care®” in 2020.